Bioventus (BVS) News Today $7.40 +0.15 (+2.07%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$7.28 -0.12 (-1.55%) As of 08/29/2025 07:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock BVS Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Invesco Ltd. Buys 248,932 Shares of Bioventus Inc. $BVSSeptember 1 at 3:31 AM | marketbeat.comVanguard Group Inc. Buys 92,143 Shares of Bioventus Inc. $BVSAugust 31 at 3:07 AM | marketbeat.comBioventus Inc. $BVS Stock Holdings Lifted by American Century Companies Inc.August 29 at 3:46 AM | marketbeat.comNuveen LLC Takes $4.70 Million Position in Bioventus Inc. $BVSAugust 29 at 3:36 AM | marketbeat.comNemaura Medical (NASDAQ:NMRD) versus Bioventus (NYSE:BVS) Financial ContrastAugust 27, 2025 | americanbankingnews.comCraig-Hallum Reiterates a Buy Rating on Bioventus (BVS), Sets a $15 PTAugust 13, 2025 | msn.comCanaccord Genuity Sticks to Its Buy Rating for Bioventus (BVS)August 12, 2025 | theglobeandmail.comCantor Fitzgerald Comments on Bioventus FY2025 EarningsAugust 12, 2025 | marketbeat.comBioventus (NYSE:BVS) Releases FY 2025 Earnings GuidanceAugust 8, 2025 | marketbeat.comBioventus to Present at the Canaccord Genuity 45th Annual Global Growth ConferenceAugust 7, 2025 | globenewswire.comBioventus (NYSE:BVS) Trading 8.6% Higher - Here's What HappenedAugust 7, 2025 | marketbeat.comBioventus Inc. (BVS) Q2 2025 Earnings Call TranscriptAugust 7, 2025 | seekingalpha.comBioventus Inc. Reports Q2 2025 Financial ResultsAugust 7, 2025 | tipranks.comBioventus Inc. 2025 Q2 - Results - Earnings Call PresentationAugust 6, 2025 | seekingalpha.comBioventus Reports Second Quarter Financial ResultsAugust 6, 2025 | globenewswire.comBioventus Enters into a New $400 Million Senior Secured Credit Agreement Lowering Interest Expense and Providing Increased LiquidityAugust 4, 2025 | globenewswire.comBioventus Receives FDA 510(k) Clearances for two Next-Generation Peripheral Nerve Stimulation ProductsJuly 30, 2025 | globenewswire.comBioventus to Report Second Quarter of Fiscal Year 2025 Financial Results on August 6, 2025July 29, 2025 | globenewswire.comRoyce & Associates LP Raises Position in Bioventus Inc. (NYSE:BVS)July 27, 2025 | marketbeat.comSegall Bryant & Hamill LLC Sells 303,082 Shares of Bioventus Inc. (NYSE:BVS)July 20, 2025 | marketbeat.comCantor Fitzgerald Initiates Coverage of Bioventus (BVS) with an Overweight RatingJuly 16, 2025 | finance.yahoo.comBioventus (NYSE:BVS) Shares Down 4.4% - Time to Sell?July 11, 2025 | marketbeat.comWith 36% stake, Bioventus Inc. (NASDAQ:BVS) seems to have captured institutional investors' interestJuly 10, 2025 | finance.yahoo.comCantor Fitzgerald Initiates Coverage of Bioventus (BVS) with Overweight RecommendationJuly 8, 2025 | msn.comBioventus (NYSE:BVS) Coverage Initiated at Cantor FitzgeraldJuly 7, 2025 | marketbeat.comBioventus (NYSE:BVS) Shares Down 3.6% - Should You Sell?June 26, 2025 | marketbeat.comDo Options Traders Know Something About Bioventus Stock We Don't?June 13, 2025 | msn.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Invests $684,000 in Bioventus Inc. (NYSE:BVS)June 12, 2025 | marketbeat.comMillennium Management LLC Sells 60,811 Shares of Bioventus Inc. (NYSE:BVS)May 31, 2025 | marketbeat.comNuveen Asset Management LLC Grows Stake in Bioventus Inc. (NYSE:BVS)May 30, 2025 | marketbeat.comD. E. Shaw & Co. Inc. Sells 160,974 Shares of Bioventus Inc. (NYSE:BVS)May 24, 2025 | marketbeat.comBNP Paribas Financial Markets Invests $1.66 Million in Bioventus Inc. (NYSE:BVS)May 21, 2025 | marketbeat.comBioventus Inc. (NYSE:BVS) Shares Sold by Cubist Systematic Strategies LLCMay 19, 2025 | marketbeat.comDimensional Fund Advisors LP Purchases 152,311 Shares of Bioventus Inc. (NYSE:BVS)May 15, 2025 | marketbeat.comAlgert Global LLC Makes New $704,000 Investment in Bioventus Inc. (NYSE:BVS)May 13, 2025 | marketbeat.comBioventus Inc. (NYSE:BVS) Shares Bought by Driehaus Capital Management LLCMay 12, 2025 | marketbeat.comCaption Management LLC Makes New Investment in Bioventus Inc. (NYSE:BVS)May 9, 2025 | marketbeat.comBioventus (NYSE:BVS) Updates FY 2025 Earnings GuidanceMay 8, 2025 | marketbeat.comBioventus Inc. (NASDAQ:BVS) Q1 2025 Earnings Call TranscriptMay 7, 2025 | insidermonkey.comBioventus reports Q1 revenue and earnings above estimates, shares dipMay 7, 2025 | investing.comBioventus: Q1 Earnings SnapshotMay 7, 2025 | finance.yahoo.comBioventus Inc (BVS) Q1 2025 Earnings Call Highlights: Navigating Growth Amidst DivestituresMay 7, 2025 | finance.yahoo.comBioventus Reports First Quarter Financial ResultsMay 6, 2025 | globenewswire.comTudor Investment Corp ET AL Lowers Holdings in Bioventus Inc. (NYSE:BVS)May 6, 2025 | marketbeat.comInvesco Ltd. Has $201,000 Stock Holdings in Bioventus Inc. (NYSE:BVS)May 6, 2025 | marketbeat.comExamining the Future: Bioventus's Earnings OutlookMay 5, 2025 | benzinga.comMarshall Wace LLP Sells 307,404 Shares of Bioventus Inc. (NYSE:BVS)May 4, 2025 | marketbeat.comNantahala Capital Management LLC Sells 324,061 Shares of Bioventus Inc. (NYSE:BVS)April 30, 2025 | marketbeat.comBioventus to Report First Quarter of Fiscal Year 2025 Financial Results on May 6, 2025April 28, 2025 | globenewswire.comOberweis Asset Management Inc. Buys 90,800 Shares of Bioventus Inc. (NYSE:BVS)April 27, 2025 | marketbeat.com Get Bioventus News Delivered to You Automatically Sign up to receive the latest news and ratings for BVS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BVS Media Mentions By Week BVS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BVS News Sentiment▼1.431.11▲Average Medical News Sentiment BVS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BVS Articles This Week▼52▲BVS Articles Average Week Get the Latest News and Ratings for BVS and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Bioventus and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Liquidia Technologies News PROCEPT BioRobotics News LeMaitre Vascular News Artivion News National Vision News Enovis News CONMED News NovoCure News SS Innovations International News Establishment Labs News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:BVS) was last updated on 9/1/2025 by MarketBeat.com Staff From Our PartnersNew Banking Law #1582 Could Unlock $21 Trillion for AmericansDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A new set of 7 AI stocks are DOMINATING the market. Here’s why one financial guru says they could be the mo...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bioventus Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bioventus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.